SEC FILE NUMBER: 2-93826-W
                                                   CUSIP NUMBER: 166746107



                               UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                                FORM 12b-25

                        NOTIFICATION OF LATE FILING

(Check One):  [ ] Form 10-K   [ ] Form 20-F   [ ] Form 11-K  
                              [x] Form 10-Q   [ ] Form N-SAR

              For Period Ended:  June 30, 1997
              [  ] Transition Report on Form 10-K
              [  ] Transition Report on Form 20-F
              [  ] Transition Report on Form 11-K
              [  ] Transition Report on Form 10-Q
              [  ] Transition Report on Form N-SAR
              For the Transition Period Ended:                             


Read Instruction (on back page) Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has 
verified any information contained herein.


If the notification relates to a portion of the filing checked above, 
identify the Item(s) to which the notification relates:

                                                                           

PART I - REGISTRANT INFORMATION

Cheung Laboratories, Inc.                                                  
Full Name of Registrant

                                                                           
Former Name if Applicable

10220-I Old Columbia Road                                                  
Address of Principal Executive Office (Street and Number)

Columbia, Maryland 21046                                                   
City, State and Zip Code

PART II - RULES 12b-25(b) AND  

If the subject report could not be filed without unreasonable effort or 
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed.  (Check box if appropriate)



(a)
The reasons described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;


[x]
(b)
The subject annual report, semi-annual report; transition report on Form 
10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or 
before the fifteenth calendar day following the prescribed due date; or the 
subject quarterly report of transition report on Form 10-Q, or portion 
thereof will be filed on or before the fifth calendar day following the 
prescribed due date; and

 
The accountant's statement or other exhibit required by Rule 12b-25  has 
been attached if applicable.


PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, 
N-SAR, or the transition report or portion thereof, could not be filed 
within the prescribed time period.  (Attach Extra Sheets If Needed)

   The accountant has not been available to finalize the financial statements
    for the quarter ended June 30, 1997 due to sickness.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this 
notification

      Douglas Liu                      (410)                  290-5390  
        (Name)                       (Area Code)         (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of 
    the Securities Exchange Act of 1934 or Section 30 of the Investment 
    Company Act of 1940 during the preceding 12 months (or for such shorter)
    period that the registrant was required to file such reports) been filed?
    If answer is no, identify report(s).[x] Yes   [ ] No
                                                                           

(3) Is it anticipated that any significant change in results of operations 
    from the corresponding period for the last fiscal year will be reflected 
    by the earnings statements to be included in the subject report or 
    portion thereof?[x] Yes   [ ] No

    If so, attach an explanation of the anticipated change, both narratively 
    and quantitatively, and, if appropriate, state the reasons why a 
    reasonable estimate of the results cannot be made.

         The net loss for the quarter ended 6/30/1996 was $330,103, the net 
         loss for the quarter ended 6/30/1997 is expected to be approximately
         $995,635. The increase is primarily due to increase in consulting, 
         legal, research & development, and compensation expenses. 

                                                                           


                         Cheung Laboratories, Inc.
               (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned 
hereunto duly authorized.


Date      August 14 , 1997             By   /s/John Mon    
                                    John Mon, Treasurer 

INSTRUCTION:  The form may be signed by an executive officer of the 
registrant or by any other duly authorized representative. The name and 
title of the person signing the form shall be typed or printed beneath the 
signature.  If the statement is signed on behalf of the registrant by an 
authorized representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be 
filed with the form.


ATTENTION


Intentional Misstatements or omissions of fact constitute Federal Criminal 
Violations (See 18 U.S.C. 1001).